16-1195518-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_021098.3(CACNA1H):​c.498C>T​(p.Tyr166Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00254 in 1,604,376 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0048 ( 10 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 40 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.66

Publications

3 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 16-1195518-C-T is Benign according to our data. Variant chr16-1195518-C-T is described in ClinVar as [Benign]. Clinvar id is 460135.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.66 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00479 (729/152234) while in subpopulation EAS AF = 0.0309 (160/5172). AF 95% confidence interval is 0.027. There are 10 homozygotes in GnomAd4. There are 508 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 729 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.459C>T p.Tyr153Tyr synonymous_variant Exon 4 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.459C>T p.Tyr153Tyr synonymous_variant Exon 4 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.498C>T p.Tyr166Tyr synonymous_variant Exon 4 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.498C>T non_coding_transcript_exon_variant Exon 4 of 35 ENSP00000518777.1

Frequencies

GnomAD3 genomes
AF:
0.00480
AC:
730
AN:
152116
Hom.:
10
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.0311
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.0430
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000926
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00613
AC:
1423
AN:
232222
AF XY:
0.00597
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000914
Gnomad ASJ exome
AF:
0.00600
Gnomad EAS exome
AF:
0.0274
Gnomad FIN exome
AF:
0.0355
Gnomad NFE exome
AF:
0.000993
Gnomad OTH exome
AF:
0.00503
GnomAD4 exome
AF:
0.00230
AC:
3347
AN:
1452142
Hom.:
40
Cov.:
34
AF XY:
0.00226
AC XY:
1631
AN XY:
721216
show subpopulations
African (AFR)
AF:
0.0000600
AC:
2
AN:
33336
American (AMR)
AF:
0.0000690
AC:
3
AN:
43450
Ashkenazi Jewish (ASJ)
AF:
0.00733
AC:
190
AN:
25928
East Asian (EAS)
AF:
0.0210
AC:
826
AN:
39288
South Asian (SAS)
AF:
0.00136
AC:
114
AN:
83992
European-Finnish (FIN)
AF:
0.0321
AC:
1690
AN:
52646
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5710
European-Non Finnish (NFE)
AF:
0.000274
AC:
303
AN:
1107738
Other (OTH)
AF:
0.00363
AC:
218
AN:
60054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
193
387
580
774
967
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00479
AC:
729
AN:
152234
Hom.:
10
Cov.:
33
AF XY:
0.00683
AC XY:
508
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41534
American (AMR)
AF:
0.000131
AC:
2
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.0309
AC:
160
AN:
5172
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4826
European-Finnish (FIN)
AF:
0.0430
AC:
456
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000927
AC:
63
AN:
67996
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00137
Hom.:
3
Bravo
AF:
0.00189
Asia WGS
AF:
0.0170
AC:
59
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.45
CADD
Benign
8.3
DANN
Benign
0.96
PhyloP100
2.7
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58142268; hg19: chr16-1245518; API